Adipose triglyceride lipase gene expression in human visceral obesity. 2008

J Berndt, and S Kralisch, and N Klöting, and K Ruschke, and M Kern, and M Fasshauer, and M R Schön, and M Stumvoll, and M Blüher
Department of Medicine, University of Leipzig, Leipzig, Germany.

In comparison to subcutaneous (SC) fat, visceral adipose tissue is more sensitive to catecholamine-induced lipolysis and less sensitive to the antilipolytic effects of insulin. Variation in the expression of lipoprotein lipase (LPL) and hormone-sensitive lipase (HSL) have been reported. We therefore hypothesized that expression of adipose triglyceride lipase (ATGL) is different in visceral and SC depot and investigated whether ATGL mRNA expression is related to obesity, fat distribution and insulin sensitivity. ATGL, LPL, and HSL mRNA expression was measured in 85 paired samples of omental and subcutaneous adipose tissue in normal glucose tolerant lean and obese individuals. In addition, we included a subgroup of obese (BMI >30 kg/m2) individuals with either impaired or preserved insulin sensitivity determined by euglycemic-hyperinsulinemic clamps. ATGL mRNA levels are significantly decreased in insulin resistant obese subjects. Independently of body fat mass, omental ATGL mRNA correlates with fasting insulin concentration, glucose uptake during the steady state of the clamp and HSL mRNA expression. In obese, but not in lean subjects, LPL and HSL mRNA expression was significantly higher in omental compared to SC fat. In both depots, HSL mRNA was significantly lower in obese individuals. Visceral HSL mRNA expression is closely related to adipocyte size and fasting plasma insulin concentrations, whereas visceral fat area significantly predicts visceral LPL mRNA expression. ATGL mRNA expression is not significantly different between omental and SC fat. HSL, but not ATGL mRNA expression is closely related to individual and regional differences in adipocyte size. Impaired insulin sensitivity was associated with decreased ATGL and HSL mRNA expression, independently of body fat mass and fat distribution.

UI MeSH Term Description Entries
D008049 Lipase An enzyme of the hydrolase class that catalyzes the reaction of triacylglycerol and water to yield diacylglycerol and a fatty acid anion. It is produced by glands on the tongue and by the pancreas and initiates the digestion of dietary fats. (From Dorland, 27th ed) EC 3.1.1.3. Triacylglycerol Lipase,Tributyrinase,Triglyceride Lipase,Acid Lipase,Acid Lipase A,Acid Lipase B,Acid Lipase I,Acid Lipase II,Exolipase,Monoester Lipase,Triacylglycerol Hydrolase,Triglyceridase,Triolean Hydrolase,Hydrolase, Triacylglycerol,Hydrolase, Triolean,Lipase A, Acid,Lipase B, Acid,Lipase I, Acid,Lipase II, Acid,Lipase, Acid,Lipase, Monoester,Lipase, Triglyceride
D008071 Lipoprotein Lipase An enzyme of the hydrolase class that catalyzes the reaction of triacylglycerol and water to yield diacylglycerol and a fatty acid anion. The enzyme hydrolyzes triacylglycerols in chylomicrons, very-low-density lipoproteins, low-density lipoproteins, and diacylglycerols. It occurs on capillary endothelial surfaces, especially in mammary, muscle, and adipose tissue. Genetic deficiency of the enzyme causes familial hyperlipoproteinemia Type I. (Dorland, 27th ed) EC 3.1.1.34. Heparin-Clearing Factor,Lipemia-Clearing Factor,Diacylglycerol Lipase,Diglyceride Lipase,Post-Heparin Lipase,Postheparin Lipase,Postheparin Lipoprotein Lipase,Factor, Heparin-Clearing,Factor, Lipemia-Clearing,Heparin Clearing Factor,Lipase, Diacylglycerol,Lipase, Diglyceride,Lipase, Lipoprotein,Lipase, Post-Heparin,Lipase, Postheparin,Lipase, Postheparin Lipoprotein,Lipemia Clearing Factor,Lipoprotein Lipase, Postheparin,Post Heparin Lipase
D008297 Male Males
D009765 Obesity A status with BODY WEIGHT that is grossly above the recommended standards, usually due to accumulation of excess FATS in the body. The standards may vary with age, sex, genetic or cultural background. In the BODY MASS INDEX, a BMI greater than 30.0 kg/m2 is considered obese, and a BMI greater than 40.0 kg/m2 is considered morbidly obese (MORBID OBESITY).
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000273 Adipose Tissue Specialized connective tissue composed of fat cells (ADIPOCYTES). It is the site of stored FATS, usually in the form of TRIGLYCERIDES. In mammals, there are two types of adipose tissue, the WHITE FAT and the BROWN FAT. Their relative distributions vary in different species with most adipose tissue being white. Fatty Tissue,Body Fat,Fat Pad,Fat Pads,Pad, Fat,Pads, Fat,Tissue, Adipose,Tissue, Fatty
D014781 Viscera Any of the large interior organs in any one of the three great cavities of the body, especially in the abdomen.
D015390 Gastric Bypass Surgical procedure in which the STOMACH is transected high on the body. The resulting small proximal gastric pouch is joined to any parts of the SMALL INTESTINE by an end-to-side SURGICAL ANASTOMOSIS, depending on the amounts of intestinal surface being bypasses. This procedure is used frequently in the treatment of MORBID OBESITY by limiting the size of functional STOMACH, food intake, and food absorption. Gastroileal Bypass,Gastrojejunostomy,Greenville Gastric Bypass,Roux-en-Y Gastric Bypass,Bypass, Gastric,Bypass, Gastroileal,Bypass, Roux-en-Y Gastric,Gastric Bypass, Greenville,Gastric Bypass, Roux-en-Y,Gastrojejunostomies,Roux en Y Gastric Bypass
D015971 Gene Expression Regulation, Enzymologic Any of the processes by which nuclear, cytoplasmic, or intercellular factors influence the differential control of gene action in enzyme synthesis. Enzymologic Gene Expression Regulation,Regulation of Gene Expression, Enzymologic,Regulation, Gene Expression, Enzymologic

Related Publications

J Berndt, and S Kralisch, and N Klöting, and K Ruschke, and M Kern, and M Fasshauer, and M R Schön, and M Stumvoll, and M Blüher
October 2007, American journal of physiology. Endocrinology and metabolism,
J Berndt, and S Kralisch, and N Klöting, and K Ruschke, and M Kern, and M Fasshauer, and M R Schön, and M Stumvoll, and M Blüher
January 1969, Polskie Archiwum Medycyny Wewnetrznej,
J Berndt, and S Kralisch, and N Klöting, and K Ruschke, and M Kern, and M Fasshauer, and M R Schön, and M Stumvoll, and M Blüher
January 2005, Obesity surgery,
J Berndt, and S Kralisch, and N Klöting, and K Ruschke, and M Kern, and M Fasshauer, and M R Schön, and M Stumvoll, and M Blüher
March 2009, Poultry science,
J Berndt, and S Kralisch, and N Klöting, and K Ruschke, and M Kern, and M Fasshauer, and M R Schön, and M Stumvoll, and M Blüher
January 2011, Obesity facts,
J Berndt, and S Kralisch, and N Klöting, and K Ruschke, and M Kern, and M Fasshauer, and M R Schön, and M Stumvoll, and M Blüher
February 2021, Prostaglandins, leukotrienes, and essential fatty acids,
J Berndt, and S Kralisch, and N Klöting, and K Ruschke, and M Kern, and M Fasshauer, and M R Schön, and M Stumvoll, and M Blüher
July 2006, Diabetologia,
J Berndt, and S Kralisch, and N Klöting, and K Ruschke, and M Kern, and M Fasshauer, and M R Schön, and M Stumvoll, and M Blüher
May 1995, Arteriosclerosis, thrombosis, and vascular biology,
J Berndt, and S Kralisch, and N Klöting, and K Ruschke, and M Kern, and M Fasshauer, and M R Schön, and M Stumvoll, and M Blüher
August 2014, Genetics and molecular research : GMR,
J Berndt, and S Kralisch, and N Klöting, and K Ruschke, and M Kern, and M Fasshauer, and M R Schön, and M Stumvoll, and M Blüher
June 2009, Obesity surgery,
Copied contents to your clipboard!